Parties d'ouvrages collectifs (3)
1.
Kollmann, T. R., Dauby, N., Harbeson, D. D., Fidanza, M., & Marchant, A. (2021). Host Defense Mechanisms Against Bacteria. In R. Polin, S. Abman, W. Benitz, & D. Rowitch (Eds.), Fetal and Neonatal Physiology. Philadelphia: Elsevier. Articles dans des revues avec comité de lecture (142)
1.
Gemander, N., Neumann, J., Veiga, R., Etienne, I., Prezzemolo, T., Kemlin, D., Pannus, P., Depickère, S., Olislagers, V., Vu Duc, I., Waegemans, A., Gerbaux, M., Bücken, L., Dahma, H., Martin, C., Dauby, N., Goossens, M. M., Desombere, I., Roca, C. P., Willemsen, M., Goriely, S., Le Moine, A., Marchant, A., Liston, A., & Humblet-Baron, S. (2025). Systems vaccinology identifies immunological correlates of SARS-CoV-2 vaccine response in solid organ transplant recipients. NPJ vaccines, 10(1), 140. doi:10.1038/s41541-025-01182-13.
Touré, Y., Martin, C., Necsoi, C. V., Delforge, M., Konopnicki, D., & Dauby, N. (2025). Experience of maternal immunization among women living with HIV in Belgium: A mixed-methods study. Preventive medicine reports, 54, 103107. doi:10.1016/j.pmedr.2025.1031075.
Van Laethem, J., Planken, S., Cortoos, P.-J., De Scheerder, M.-A., Kiselinova, M., Tilmanne, A., Yusuf, E., Vansintejan, J., & Dauby, N. (2025). Improving effective antimicrobial resistance (AMR) prevention in ambulatory care: lessons from secondary appraisal of Belgian anti-infectious treatment care guidelines. European journal of clinical microbiology & infectious diseases. doi:10.1007/s10096-025-05075-y6.
Doubinsky, A., Miendje Deyi, V. Y., Mattheus, W., Delforge, M., Libois, A., Dauby, N., & Nasreddine, R. (2024). Prevalence of Neisseria meningitidis carriage among men who have sex with men at a sexual health clinic in Brussels, Belgium: a cross-sectional study. European journal of clinical microbiology & infectious diseases. doi:10.1007/s10096-024-05031-27.
Bruyneel, A., Dauvergne, J. E., Dauby, N., Goffard, J.-C., Rea, A., & Racapé, J. (2024). Social health gradient and risk factors among patients hospitalized for COVID-19 and pre-pandemic respiratory infections. A linked national individual case-control study in Belgium. Frontiers in Public Health. doi:https://doi.org/10.3389/fpubh.2024.14268988.
Augello, M., Wagenhäuser, I., Krone, M., Dauby, N., Ferrara, P., Sabbatucci, M., Ruta, S., Rezahosseini, O., Velikov, P., Gkrania-Klotsas, E., Montes, J., Franco-Paredes, C., Goodman, A. L., Küçükkaya, S., Tuells, J., Harboe, Z. B., & Epaulard, O. (2024). Should SARS-CoV-2 serological testing be used in the decision to deliver a COVID-19 vaccine booster? A pro-con assessment. Vaccine, 126184. doi:10.1016/j.vaccine.2024.126184